MoonLake Immunotherapeutics - CLASS A ORD (MLTX)

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Equity / CLASS A ORD
Number of holders
119
Total Shares
56.3M
Shares change
+608K
Total reported value, excl. options
$3.21B
Value change
+$46.6M
Put/Call ratio
13.13
Number of buys
75
Number of sells
-37
Price
$57.00
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.